Correlation of fasting and post meal plasma glucose level to increased HbA1c levels in type-2 diabetes mellitus

Shubham Gupta, Priti Vijay Puppalwar, Anita Chalak

Abstract


Background: Various observational studies and clinical trials have demonstrated that intensive glycemic control prevents the development and progression of long term diabetic micro-vascular complications and may reduce macrovascular complications. However, there is insufficient data to determine the contribution of fasting and post meal plasma glucose to increase the percentage of HbA1C level. Therefore, it is desirable to know whether fasting or post-prandial plasma glucose level alone or in combination will be necessary in adjusting the therapy to achieve optimal HbA1C levels in type-2 diabetes mellitus.The present study was aimed to correlate fasting and post meal plasma glucose level to HbA1C level in type-2 diabetes mellitus.   

Methods: 50 diagnosed uncomplicated patients of type-2 diabetes mellitus under treatment in diabetic clinic of Acharya Vinoba Bhave Rural Hospital (AVBRH) were enrolled for the study. We have used Pearson’s correlation coefficient to find the statistical significance.

Results: Both fasting as well as post-meal glucose levels were correlated with HbA1C but higher correlation was seen between fasting plasma glucose and HbA1C.

Conclusion: Our study revealed that fasting plasma glucose value appreciably contributes HbA1C as compared to post-meal glucose values.


Keywords


Diabetes mellitus, Fasting plasma glucose, Post meal plasma glucose, Glycosylated hemoglobin

Full Text:

PDF

References


Manjunatha Gaud BK, Bhavna Nayal, Sarsina Devi O, Sathisha TG, Sweta Shivashanker, Devaki RN. Relationship of calculated HbA1C with fasting plasma glucose. Int J Appl Biol Pharmacol Technol. 2011;2(2):58-61.

Sherita Golden, Todd Brown, Hsin-Chieh Yeh, Nisa Maruthur, Padmini Ranasinghe, Zack Berger, et al. Use of HbA1C and microalbuiminuria in monitoring of diabetes mellitus. Evidence Report/Technology Assessment No. 842003; 84 (04-E001), 2012.

Castilho EM, Glass ML, Manco JC. The effects of 2,3-diphosphoglycerate, adenosine triphosphate, and glycosylated hemoglobin on the hemoglobin-oxygen affinity of diabetic patients. Braz J Med Biol Res. 2003;36(6):731-7.

Nathan DM, Singer DE, Hurxthal K, Goodson JD. The clinical information value of the glycosylated hemoglobin assay. N Engl J Med. 1984;310(6):341-6. Tahara Y, Shima K. The response of GHb to stepwise plasma glucose change over time in diabetic patients. Diabet Care. 1993;16(9):1313-4.

Akinloye OA, Adaramoye OA, Akinlade KS, Odetola AA, Raji AA. Relationship between fasting plasma glucose and glycated hemoglobin in adult diabetic Nigerians. Afr J Biomed Res. 2007;10:127-32.

Distiller LA, Zail SS. The Use of glycosylated haemoglobin measurements in the Control of the diabetic patient. S Afr Med J. 1979;55:335.

Alam T, Weintraub N, Weinreb J. What is the proper use of hemoglobin A1C monitoring in the elderly? J Am Med Dir Assoc. 2006;7:S60-4

Peter A, Fritsche A, Stefan N, Heni M, Häring HU, Schleicher E. Diagnostic value of hemoglobin A1C for type 2 diabetes mellitus in a population at risk. Exp Clinical Endocrinol Diabet. 2011 Apr;119(4):234-7.

Medicine net. Hemoglobin A1C Test, 2014. Avialable at: Medicinenet.com/hemoglobin_a1c_test/article.htm

Rudiger Landgraf. Relationship of postprandial glucose to HbA1C. Diabet/Metab Res Rev. 2004;20(2):S9-12.

Carl A. Burtis, Edward R. Ashwood, Barbara Border, Norbert W. Tietz. GOD-POD method. In: Carl A. Burtis, Edward R. Ashwood, Norbert W. Tietz, eds. Fundamentals of Clinical Chemistry. 2nd ed. Toronto: W.B. Saunders; 1982: 242-251.

Little RR. Recent Progress in HbA1c testing. Diabet Care. 2000 Mar;23(3):265-6.

Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Source - Madras diabetes research foundation & Dr. Mohan's diabetes specialities centre. Indian J Med Res. 2007 Mar;3(125):217-30.

Azim W, Mushtaq Gill M, Azim S, Farooq W. Assessment of fasting and two-hour post-prandial glucose as an economical test for monitoring of glycemic control, compared to glycated haemoglobin. Med Channel. 2011;17(2):5-7.

Bonora E, Calcaterra F, Lombardi S, Bonfante N, Formentini G, Bonadonna RC, et al. Plasma glucose levels throughout the day and HbA1C interrelationships control in type 2 diabetes: implications for treatment and monitoring of metabolic control. Diabet Care. 2001 Dec;24(12):2023-9.

Saiedullah M, Begum S, Shermin S, Rahman MR, Khan MAH. Relationship of glycosylated hemoglobin with fasting and postprandial plasma glucose in nondiabetic, pre-diabetic and newly diagnosed diabetic subjects. Bangladesh Med J. 2011:40(1):37.

Monnier L, Lapinski H, Colette C. Contributions of fasting and post-prandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA1C. Diabet Care. 2003 Mar;26(3):881-5.

Riddle M1, Umpierrez G, DiGenio A, Zhou R, Rosenstock J. Contribution of basal and postprandial hyperglycemia over wide range of A1C levels before and after treatment intensification in type 2 diabetes. Diabet Care. 2011 Dec;34(12):2508-14.

Monnier L, Colette C. Contributions of fasting and postprandial glucose to hemoglobin A1C. Endocr Pract. 2006 Jan-Feb;12(Suppl 1):42-6.

S. W. Masram, M. V. Bimanpalli. Assessment of contribution of fasting and post meal plasma glucose to increased HbA1C in diabetes mellitus-comparative study. Int J Biol Med Res. 2012;3(3):2020-4.

Rosediani M, Azidah AK, Mafauzy M. Correlation between fasting plasma glucose, post prandial glucose and glycated haemoglobin and fructosamine. Med J Malaysia. 2006 Mar;61(1):67-71.

Antonio Ceriello, Stephen Colagiuri, John Gerich, Jaakko Tuomilehto. Guideline for management of post meal glucose. Rev Nutr Metab Cardiovasc Dis. 2008;18:S17-33.

Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-86.

Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients. Diabet Care. 2000;23(Suppl. 2):B21-9.